Benzinga | Aug 9, 2021 04:38PM EDT

Atara Biotherapeutics Q2 EPS $(0.91) Misses $(0.89) Estimate, Sales $3.87M Beat $3.84M Estimate

Atara Biotherapeutics (NASDAQ:ATRA) reported quarterly losses of $(0.91) per share which missed the analyst consensus estimate of $(0.89) by 2.25 percent. This is a 20.18 percent increase over losses of $(1.14) per share from the same period last year. The company reported quarterly sales of $3.87 million which beat the analyst consensus estimate of $3.84 million by 0.78 percent.